Entrada Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
(NasdaqGM:TRDA), BOSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that Dipal Doshi, Chief Executive Officer, will deliver a company presentation at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 3:45 PM PT (6:45 PM ET). A live webcast will be available on the Presentations […]